| The International Human Epigenome Consortium: a blueprint for scientific collaboration and discovery HG Stunnenberg, S Abrignani, D Adams, M de Almeida, L Altucci, V Amin, ... Cell 167 (5), 1145-1149, 2016 | 546 | 2016 |
| The emergence of an ethical duty to disclose genetic research results: international perspectives BM Knoppers, Y Joly, J Simard, F Durocher European Journal of Human Genetics 14 (11), 1170-1178, 2006 | 330 | 2006 |
| Prepublication data sharing Toronto International Data Release Workshop Authors Nature 461 (7261), 168-170, 2009 | 220 | 2009 |
| Genetic discrimination and life insurance: a systematic review of the evidence Y Joly, I Ngueng Feze, J Simard BMC medicine 11, 1-15, 2013 | 183 | 2013 |
| GA4GH: International policies and standards for data sharing across genomic research and healthcare HL Rehm, AJH Page, L Smith, JB Adams, G Alterovitz, LJ Babb, ... Cell genomics 1 (2), 2021 | 178 | 2021 |
| Epigenome-based cancer risk prediction: rationale, opportunities and challenges M Widschwendter, A Jones, I Evans, D Reisel, J Dillner, K Sundström, ... Nature reviews Clinical oncology 15 (5), 292-309, 2018 | 160 | 2018 |
| A review of the key issues associated with the commercialization of biobanks T Caulfield, S Burningham, Y Joly, Z Master, M Shabani, P Borry, ... Journal of Law and the Biosciences 1 (1), 94-110, 2014 | 152 | 2014 |
| Data sharing in the post-genomic world: the experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO) Y Joly, ES Dove, BM Knoppers, M Bobrow, D Chalmers PLoS computational biology 8 (7), e1002549, 2012 | 125 | 2012 |
| Integrating artificial intelligence into health care through data access: can the GDPR act as a beacon for policymakers? MB Forcier, H Gallois, S Mullan, Y Joly Journal of Law and the Biosciences 6 (1), 317-335, 2019 | 115 | 2019 |
| Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer J Simard, M Dumont, AM Moisan, V Gaborieau, H Vézina, F Durocher, ... Journal of medical genetics 44 (2), 107-121, 2007 | 111 | 2007 |
| Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users’ views G Bertier, M Hétu, Y Joly BMC medical genomics 9, 1-12, 2016 | 108 | 2016 |
| Genomic cloud computing: legal and ethical points to consider ES Dove, Y Joly, AM Tassé, BM Knoppers European Journal of Human Genetics 23 (10), 1271-1278, 2015 | 101 | 2015 |
| Ethical issues of CRISPR technology and gene editing through the lens of solidarity JJ Mulvihill, B Capps, Y Joly, T Lysaght, HAE Zwart, R Chadwick, ... British medical bulletin 122 (1), 17-29, 2017 | 99 | 2017 |
| Open science versus commercialization: a modern research conflict? T Caulfield, SHE Harmon, Y Joly Genome medicine 4, 1-11, 2012 | 96 | 2012 |
| Reflections on the cost of" low-cost" whole genome sequencing: framing the health policy debate T Caulfield, J Evans, A McGuire, C McCabe, T Bubela, R Cook-Deegan, ... PLoS biology 11 (11), e1001699, 2013 | 88 | 2013 |
| Personalized risk assessment for prevention and early detection of breast cancer: integration and implementation (PERSPECTIVE I&I) JD Brooks, H Nabi, IL Andrulis, AC Antoniou, J Chiquette, P Després, ... Journal of personalized medicine 11 (6), 511, 2021 | 80 | 2021 |
| Comparative approaches to genetic discrimination: chasing shadows? Y Joly, IN Feze, L Song, BM Knoppers Trends in Genetics 33 (5), 299-302, 2017 | 80 | 2017 |
| Genetic discrimination in private insurance: global perspectives Y Joly, M Braker, M Le Huynh New genetics and society 29 (4), 351-368, 2010 | 78 | 2010 |
| Are data sharing and privacy protection mutually exclusive? Y Joly, SOM Dyke, BM Knoppers, T Pastinen Cell 167 (5), 1150-1154, 2016 | 68 | 2016 |
| Life insurance: genomic stratification and risk classification Y Joly, H Burton, BM Knoppers, IN Feze, T Dent, N Pashayan, ... European Journal of Human Genetics 22 (5), 575-579, 2014 | 67 | 2014 |
